Transcriptomics

Dataset Information

0

RNA-sequencing demonstrates transcriptional differences between human vocal fold fibroblasts and myofibroblasts


ABSTRACT: Background: Differentiation of fibroblasts into myofibroblasts is necessary for wound healing, but excessive myofibroblast presence and persistence can result in scarring. Treatment for scarring is limited largely due to a lack of comprehensive understanding of how fibroblasts and myofibroblasts differ at the transcript level. The purpose of the study was to comprehensively characterize transcriptional profiles of injured fibroblasts relative to normal fibroblasts, utilizing fibroblasts from the vocal fold as a model for other areas of the body. Results: we identified differentially expressed genes between groups of normal fibroblasts, scarred fibroblasts, and fibroblasts treated with transforming growth factor-beta 1 (TGF-β1), which represented an induced-scar phenotype. Principal component analysis revealed clustering of normal fibroblasts separate from the clustering of fibroblasts treated with TGF-β1; scarred fibroblasts were more similar to normal fibroblasts than fibroblasts treated with TGF-β1. Enrichment analyses revealed pathways related to cell signaling, receptor-ligand activity, and regulation of cell functions in scarred fibroblasts, pathways related to cell adhesion in normal fibroblasts, and pathways related to ECM binding in fibroblasts treated with TGF-β1. Although transcriptomic profiles between scarred fibroblasts and fibroblasts treated with TGF-β1 were relatively dissimilar, the most highly co-expressed genes were enriched in pathways related to actin cytoskeleton binding. Conclusions: Transcriptomics of normal fibroblasts differ from myofibroblasts, including from those retrieved from scar and those treated with TGF-β1. Despite large differences in transcriptomics between tVFF and sVFF, tVFF serve as a useful in vitro model of myofibroblasts and highlight key similarities to myofibroblasts extracted from scar pathology, as well as expected differences related to normal fibroblasts from healthy VF.

ORGANISM(S): Homo sapiens

PROVIDER: GSE278852 | GEO | 2025/03/25

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-09-24 | GSE248960 | GEO
2015-06-30 | E-GEOD-63659 | biostudies-arrayexpress
2024-09-24 | GSE248759 | GEO
2013-09-02 | E-GEOD-48839 | biostudies-arrayexpress
2016-08-18 | E-MTAB-4810 | biostudies-arrayexpress
2024-07-24 | GSE271672 | GEO
2024-07-24 | GSE271671 | GEO
2024-07-03 | PXD051197 | Pride
2021-11-22 | GSE189134 | GEO
2025-02-21 | GSE287915 | GEO